These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 411723)

  • 1. Repeated blood glucose and plasma insulin levels in normal volunteer subjects receiving isocaloric meals, before and after chlorpropamide and glibenclamide.
    Owens DR; Seldrup J; Wragg KG; Shetty KJ; Biggs PI
    Horm Metab Res; 1977 Sep; 9(5):347-51. PubMed ID: 411723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P; Oksala H; Pitkäjärvi T
    Arzneimittelforschung; 1985; 35(10):1596-9. PubMed ID: 3935120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate receptors and the metabolic response to intravenous glucose.
    Leslie RD; Eff C; Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Alberti KG
    Diabete Metab; 1982 Sep; 8(3):235-9. PubMed ID: 6292013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
    Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
    Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma high density lipoprotein cholesterol in streptozotocin diabetic and non-diabetic mice after prolonged administration of glibenclamide, chlorpropamide and metformin.
    Billingham MS; Hall RA; Simpson S; Bailey CJ
    Diabete Metab; 1981 Dec; 7(4):271-4. PubMed ID: 6800858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reproducibility of serial meal and oral glucose tolerance tests in normal subjects.
    Owens DR; Wragg KG; Biggs PI; Luzio S; Davies CJ; Jones MK
    Diabete Metab; 1981 Mar; 7(1):25-33. PubMed ID: 7016619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats.
    Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR
    Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
    Cooper MB; Al Majali K; Bailey CJ; Betteridge DJ
    Clin Endocrinol (Oxf); 2008 May; 68(5):738-46. PubMed ID: 17980009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
    Massi-Benedetti M; Herz M; Pfeiffer C
    Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.